Nitroimidazoles Part 10. Synthesis, crystal structure, molecular docking, and anticancer evaluation of 4-nitroimidazole derivatives combined with piperazine moiety.

IF 1.8 4区 生物学 Q4 BIOCHEMISTRY & MOLECULAR BIOLOGY
Yaseen A Al-Soud, Sadeekah O W Saber, Amneh Shtaiwi, Sondos O Alsawakhneh, Kafa' A S Alhelal, Qusay F A Salman, Luay Abu-Qatouseh, Monther A Khanfar, Raed A Al-Qawasmeh
{"title":"Nitroimidazoles Part 10. Synthesis, crystal structure, molecular docking, and anticancer evaluation of 4-nitroimidazole derivatives combined with piperazine moiety.","authors":"Yaseen A Al-Soud,&nbsp;Sadeekah O W Saber,&nbsp;Amneh Shtaiwi,&nbsp;Sondos O Alsawakhneh,&nbsp;Kafa' A S Alhelal,&nbsp;Qusay F A Salman,&nbsp;Luay Abu-Qatouseh,&nbsp;Monther A Khanfar,&nbsp;Raed A Al-Qawasmeh","doi":"10.1515/znc-2022-0023","DOIUrl":null,"url":null,"abstract":"<p><p>Piperazine-tagged imidazole derivatives <b>3a</b> (symmetrical di-substituted piperazine) and <b>5</b>-<b>11</b> were synthesized through the combination of 4-nitroimidazole derivatives with piperazine moiety. The structural characterization was done by different physical and spectral techniques like NMR (<sup>1</sup>H and <sup>13</sup>C) and mass spectrometry. The constituency of compound <b>3a</b> was confirmed by X-ray structural analyses. All compounds were assessed for their antiproliferative inhibition potency against five human cancer cell lines namely MCF-7, PC3, MDA-231, A549 and Fibro dental. Compound <b>5</b> was found to be the most potent anticancer agents against MCF-7 cell line with IC<sub>50</sub> values of (1.0 ± 0 µm) and against PC3 with IC<sub>50</sub> value of (9.00 ± 0.028 µm). The molecular docking of compound <b>5</b> had been studied, and the results revealed that the newly designed 4-nitroimidazole combined with piperazine moiety derivatives bond to the hydrophobic pocket and polar contacts with high affinity.</p>","PeriodicalId":49344,"journal":{"name":"Zeitschrift Fur Naturforschung Section C-A Journal of Biosciences","volume":"78 3-4","pages":"93-103"},"PeriodicalIF":1.8000,"publicationDate":"2023-03-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Zeitschrift Fur Naturforschung Section C-A Journal of Biosciences","FirstCategoryId":"99","ListUrlMain":"https://doi.org/10.1515/znc-2022-0023","RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"BIOCHEMISTRY & MOLECULAR BIOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Piperazine-tagged imidazole derivatives 3a (symmetrical di-substituted piperazine) and 5-11 were synthesized through the combination of 4-nitroimidazole derivatives with piperazine moiety. The structural characterization was done by different physical and spectral techniques like NMR (1H and 13C) and mass spectrometry. The constituency of compound 3a was confirmed by X-ray structural analyses. All compounds were assessed for their antiproliferative inhibition potency against five human cancer cell lines namely MCF-7, PC3, MDA-231, A549 and Fibro dental. Compound 5 was found to be the most potent anticancer agents against MCF-7 cell line with IC50 values of (1.0 ± 0 µm) and against PC3 with IC50 value of (9.00 ± 0.028 µm). The molecular docking of compound 5 had been studied, and the results revealed that the newly designed 4-nitroimidazole combined with piperazine moiety derivatives bond to the hydrophobic pocket and polar contacts with high affinity.

硝基咪唑第十部分。哌嗪基4-硝基咪唑衍生物的合成、晶体结构、分子对接及抗癌评价。
通过4-硝基咪唑衍生物与哌嗪部分的结合,合成了哌嗪标记的咪唑衍生物3a(对称二取代哌嗪)和5-11。结构表征是通过不同的物理和光谱技术,如核磁共振(1H和13C)和质谱。化合物3a的成分通过x射线结构分析得到了证实。所有化合物对五种人类癌细胞系MCF-7、PC3、MDA-231、A549和Fibro dental的抗增殖抑制能力进行了评估。化合物5对MCF-7的IC50值为(1.0±0µm),对PC3的IC50值为(9.00±0.028µm),是最有效的抗癌药物。对化合物5的分子对接进行了研究,结果表明,新设计的4-硝基咪唑与哌嗪部分衍生物与疏水口袋和极性接触具有高亲和力。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
4.10
自引率
5.00%
发文量
55
期刊介绍: A Journal of Biosciences: Zeitschrift für Naturforschung C (ZNC) is an international scientific journal and a community resource for the emerging field of natural and natural-like products. The journal publishes original research on the isolation (including structure elucidation), bio-chemical synthesis and bioactivities of natural products, their biochemistry, pharmacology, biotechnology, and their biological activity and innovative developed computational methods for predicting the structure and/or function of natural products. A Journal of Biosciences: Zeitschrift für Naturforschung C (ZNC) welcomes research papers in fields on the chemistry-biology boundary which address scientific ideas and approaches to generate and understand natural compounds on a molecular level and/or use them to stimulate and manipulate biological processes.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信